Article Text

PDF
Two-year follow-up of plasma leptin and other cytokines in patients with rheumatoid arthritis
  1. D Xibillé-Friedmann1,
  2. C Bustos-Bahena2,
  3. S Hernández-Góngora1,
  4. R Burgos-Vargas3,
  5. J L Montiel-Hernández2
  1. 1Department of Rheumatology, Hospital General de Cuernavaca “Dr José G Parres”, SSA, Cuernavaca, Morelos, México
  2. 2Cytokine and Autoimmunity Laboratory, Facultad de Farmacia, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, México
  3. 3Department of Rheumatology, Hospital General de México, SSA, México City, México
  1. Correspondence to Dr José Luis Montiel-Hernández, Facultad de Farmacia, UAEM, Av Universidad 1001, Col Chamilpa, C.P. 62209, Cuernavaca, Morelos, México; jlmontiel{at}uaem.mx

Statistics from Altmetric.com

Leptin is an adipocyte-derived hormone that may regulate the immune response.1 Its reduction is associated with increased susceptibility to infection, whereas the opposite is associated with proinflammatory cytokine production in rheumatoid arthritis (RA) and other autoimmune disorders.2 Leptin could represent a link between the immune response, metabolic functions and nutritional status.3

While the concentration of leptin may be increased in the plasma of patients with RA, in the synovial fluid it seems to be decreased.2 3 Although some reports found no difference between leptin plasma concentrations in patients with RA and healthy controls,4 we found it increased in RA, particularly in those patients with longer disease duration.5 Leptin concentration also correlated with disease …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.